Skip to content

Abdominal Exploration Without Incisions

Diagnostic Transluminal Endoscopic Peritoneoscopy

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00427752
Enrollment
20
Registered
2007-01-29
Start date
2006-10-31
Completion date
2012-01-31
Last updated
2012-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Keywords

Transgastric, Endoluminal, Peritoneoscopy, Diagnostic, Feasibility

Brief summary

This study is being conducted to determine whether an endoscope, (a small, flexible tube with a camera mounted on the end) passed down through the throat, through the stomach, and into the abdomen can safely and accurately examine the organs and tissue of the abdomen and take biopsies if needed. We wish to determine if this endoscopic diagnostic route is as efficient as the laparoscopic diagnostic route, which is currently the standard of care.

Detailed description

We propose to investigate the efficacy of transgastric endoscopic peritoneoscopy with endoscopic biopsy in patients undergoing diagnostic laparoscopy and who will require a concurrent gastrotomy for placement of a PEG, gastrojejunostomy or gastric resection. We hypothesize that diagnostic endoscopic peritoneoscopy can be done safely with adequate visualization of the abdominal cavity to direct clinical treatment.

Interventions

PROCEDURETransgastric endoscopic peritoneoscopy.

Exploration of the abdominal area

Sponsors

Stryker Nordic
CollaboratorINDUSTRY
Ethicon Endo-Surgery
CollaboratorINDUSTRY
Jeffrey Hazey
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Pancreatic Cancer undergoing staging laparoscopy * Staging or diagnostic laparoscopy in anyone needing enteral access

Exclusion criteria

* Lack of consent * Intra-abdominal adhesions precluding diagnostic laparoscopy

Design outcomes

Primary

MeasureTime frame
1) That transgastric endoscopic peritoneoscopy is feasible.4/12

Secondary

MeasureTime frame
That bacterial abdominal contamination is not clinically significant.04/11

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026